Environmental concentrations of the selective serotonin reuptake inhibitor fluoxetine impact specific behaviors involved in reproduction, feeding and predator avoidance in the fish Pimephales promelas (fathead minnow)

Aquatic Toxicology

Volumn 151, Issue , 2014, Pages 77-83

  Weinberger, Joel ^a   Klaper, Rebecca ^a  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

Fecundity; Mating; Neuroendocrine; Pharmaceuticals; Prozac; SSRI

Indexed keywords

ESTROGEN; FLUOXETINE; SURFACE WATER; TESTOSTERONE;

AGGRESSION; CONCENTRATION (COMPOSITION); DRUG; FECUNDITY; FEEDING BEHAVIOR; FISH; HORMONE; MATING BEHAVIOR; REPRODUCTIVE BEHAVIOR; SURFACE WATER; SURVIVAL;

ADULT; AGGRESSION; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BEHAVIOR CHANGE; BRAIN FUNCTION; COMPARATIVE STUDY; COMPULSION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEFENDING BEHAVIOR; EGG PRODUCTION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL IMPACT; FEEDING BEHAVIOR; FEMALE; FRESHWATER ENVIRONMENT; HORMONAL REGULATION; ISOLATION BEHAVIOR; LONG TERM EXPOSURE; MALE; MATING; MORTALITY; NESTING; NEUROENDOCRINE SYSTEM; NONHUMAN; PIMEPHALES PROMELAS; PREDATOR AVOIDANCE; PRIORITY JOURNAL; SURVIVAL RATE; WATER POLLUTION;

NORTH AMERICA;

PIMEPHALES PROMELAS;

FECUNDITY; MATING; NEUROENDOCRINE; PHARMACEUTICALS; PROZAC; SSRI;

ANIMALS; BEHAVIOR, ANIMAL; CYPRINIDAE; FEMALE; FLUOXETINE; MALE; NEUROSECRETORY SYSTEMS; REPRODUCTION; SEXUAL BEHAVIOR, ANIMAL; WATER POLLUTANTS, CHEMICAL;

EID: 84899473002     PISSN: 0166445X     EISSN: 18791514     Source Type: Journal    
DOI: 10.1016/j.aquatox.2013.10.012     Document Type: Article

References (54)

1. Airhart M.J., Lee D.H., Wilson T.D., Miller B.E., Miller M.N., Skalko R.G. Movement disorders and neurochemical changes in zebrafish larvae after bath exposure to fluoxetine (PROZAC). Neurotoxicol. Teratol. 2007, 29:652-664.
2. Barbosa Júnior A., Alves F.L., Pereira Ade S., Ide L.M., Hoffmann A. Behavioral characterization of the alarm reaction and anxiolytic-like effect of acute treatment with fluoxetine in piauçu fish. Physiol. Behav. 2012, 105:784-790.
3. Barry M.J. Effects of fluoxetine on the swimming and behavioral responses of the Arabian killifish. Ecotoxicology 2013, 22:425-432.
4. Beulig A., Fowler J. Fish on Prozac: effect of serotonin reuptake inhibitors on cognition in goldfish. Behav. Neurosci. 2008, 122(April (2)):426-432.
5. Blair B.D., Crago J.P., Hedman C.J., Klaper R. Pharmaceutical and personal care products found in the great lakes above concentrations of environmental concern. Chemosphere 2013, 93:2116-2123.
6. Blair B.D., Crago J.P., Hedman C.J., Treguer R.J.F., Magruder C., Royer L.S., Klaper R.D. Evaluation of a model for the removal of pharmaceuticals, personal care products, and hormones from wastewater. Sci. Total Environ. 2013, 444:515-521.
7. Boyd G.R., Reemtsma H., Grimm D.A., Mitra S. Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada. Sci. Total Environ. 2003, 311:135-149.
8. Brooks B.W., Brain R.A. Introduction and background for alternative nontraditional end points in aquatic toxicology. Chem. Res. Toxicol. 2010, 23. 271-271.
9. Brooks B.W., Chambliss C.K., Stanley J.K., Ramirez A., Banks K.E., Johnson R.D., Lewis R.J. Determination of select antidepressants in fish from an effluent-dominated stream. Environ. Toxicol. Chem. 2005, 24:464-469.
10. Brooks B.W., Foran C.M., Richards S.M., Weston J., Turner P.K., Stanley J.K., Solomon K.R., Slattery M., La Point T.W. Aquatic ecotoxicology of fluoxetine. Toxicol. Lett. 2003, 142:169-183.
11. Brun G.L., Bernier M., Losier R., Doe K., Jackman P., Lee H.B. Pharmaceutically active compounds in Atlantic Canadian sewage treatment plant effluents and receiving waters, and potential for environmental effects as measured by acute and chronic aquatic toxicity. Environ. Toxicol. Chem. 2006, 25:2163-2176.
12. Burt C.W., McCaig L.F., Rechtsteiner E.A. Ambulatory medical care utilization estimates for 2005. Advance data from vital and health statistics, no. 388 2007, National Center for Health Statistics, Hyattsville, MD.
13. Christensen A.M., Markussen B., Baun A., Halling-Sørensen B. Probabilistic environmental risk characterization of pharmaceuticals in sewage treatment plant discharges. Chemosphere 2009, 77:351-358.
14. Chu S., Metcalfe C.D. Analysis of paroxetine, fluoxetine and norfluoxetine in fish tissues using pressurized liquid extraction, mixed mode solid phase extraction cleanup and liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2007, 1163:112-118.
15. De Pedro N., Pinillos M.L., Valenciano A.I., Alonso-Bedate M., Delgado M.J. Inhibitory effect of serotonin on feeding behavior in goldfish: involvement of CRF. Peptides 1998, 19:505-511.
16. Domenici P., Blake R. The kinematics and performance of fish fast-start swimming. J. Exp. Biol. 1997, 200:1165-1178.
17. Dzieweczynski T.L., Herbert O.L. Fluoxetine alters behavioral consistency of aggression and courtship in male Siamese fighting fish Betta splendens. Physiol. Behav. 2012, 107:92-97.
18. Eaton R.C., Hackett J.T. The role of the Mauthner cell in fast-starts involving escape in teleost fishes. Neural Mechanisms of Startle Behavior 1984, 213-266.
19. Eaton R.C., Lee R.K.K., Foreman M.B. The Mauthner cell and other identified neurons of the brainstem escape network of fish. Prog. Neurobiol. 2001, 63:467-485.
20. Elipot Y., Hinaux H., Callebert J., Rétaux S. Evolutionary shift from fighting to foraging in blind cavefish through changes in the serotonin network. Curr. Biol. 2013, 23:1-10.
21. Fernandes D., Schnell S., Porte C. Can pharmaceuticals interfere with the synthesis of active androgens in male fish? An in vitro study. Mar. Pollut. Bull. 2011, 62:2250-2253.
22. Ferriere F., Khan N.A., Troutaud D., Deschaux P. Serotonin modulation of lymphocyte proliferation via 5-HT1A receptors in rainbow trout (Oncorhynchus mykiss). Dev. Comp. Immunol. 1996, 20:273-283.
23. Fong P. Antidepressants in aquatic organisms: a wide range of effects. Pharmaceuticals and Personal Care Products in the Environment: Scientific and Regulatory Issues 2001, 396. American Chemical Society, Washington, DC. C.G. Daughton, T.L. Jones-Lepp (Eds.).
24. Foran C.M., Weston J., Slattery M., Brooks B.W., Huggett D.B. Reproductive assessment of Japanese medaka (Oryzias latipes) following a four-week fluoxetine (SSRI) exposure. Arch. Environ. Contam. Toxicol. 2004, 46:511-517.
25. Gaworecki K.M., Klaine S.J. Behavioral and biochemical responses of hybrid striped bass during and after fluoxetine exposure. Aquat. Toxicol. 2008, 88:207-213.
26. Griffin L.D., Mellon S.H. Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:13512-13517.
27. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol. Lett. 2002, 131:5-17.
28. Jones M., Folt C., Guarda S. Characterizing individual population and community effects of sublethal levels of aquatic toxicants - an experimental case-study using Daphnia. Freshw. Biol. 1991, 26:35-44.
29. Khan I.A., Thomas P. Stimulatory effects of serotonin on maturational gonadotropin release in the Atlantic croaker Micropogonias undulatus. Gen. Comp. Endocrinol. 1992, 88:388-396.
30. Kohlert J.G., Mangan B.P., Kodra C., Drako L., Long E., Simpson H. Decreased aggressive and locomotor behaviors in Betta splendens after exposure to fluoxetine. Psychol. Rep. 2012, 110:51-62.
31. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 2002, 36:1202-1211.
32. Kostich M.S., Lazorchak J.M. Risks to aquatic organisms posed by human pharmaceutical use. Sci. Total Environ. 2008, 389:329-339.
33. Lister A., Regan C., Van Zwol J., Van Der Kraak G. Inhibition of egg production in zebrafish by fluoxetine and municipal effluents: a mechanistic evaluation. Aquat. Toxicol. 2009, 95:320-329.
34. Lovern S.B., Strickler J.R., Klaper R. Behavioral and physiological changes in Daphnia magna when exposed to nanoparticle suspensions (titanium dioxide, nano-C60, and C60HxC70Hx). Environ. Sci. Technol. 2007, 41:4465-4470.
35. Lynn S.E., Egar J.M., Walker B.G., Sperry T.S., Ramenofsky M. Fish on Prozac: a simple, noninvasive physiology laboratory investigating the mechanisms of aggressive behavior in Betta splendens. Adv. Physiol. Educ. 2007, 31:358-363.
36. Malkesman O., Pine D.S., Tragon T., Austin D.R., Henter I.D., Chen G., Manji H.K. Animal models of suicide-trait-related behaviors. Trends Pharmacol. Sci. 2009, 30:165-173.
37. Maximino C., da Silva A.W., Gouveia A., Herculano A.M. Pharmacological analysis of zebrafish (Danio rerio) scototaxis. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:624-631.
38. McDonald M.D., Gonzalez A., Sloman K.A. Higher levels of aggression are observed in socially dominant toadfish treated with the selective serotonin reuptake inhibitor, fluoxetine. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 2010, 153:107-112.
39. Mennigen J.A., Lado W.E., Zamora J.M., Duarte-Guterman P., Langlois V.S., Metcalf C.D., Change J.P., Moon T.W., Trudeau V.L. Waterborne fluoxetine disrupts the reproductive axis in sexually mature male goldfish, Carassius auratus. Aquat. Toxicol. 2010, 100:354-364.
40. Mennigen J.A., Sassine J., Trudeau V.L., Moon T.W. Waterborne fluoxetine disrupts feeding and energy metabolism in the goldfish, Carassius auratus. Aquat. Toxicol. 2010, 100:128-137.
41. Mennigen J.A., Stroud P., Zamora J.M., Moon T.W., Trudeau V.L. Pharmaceuticals as neuroendocrine disruptors: lessons learned from fish on Prozac. J. Toxicol. Environ. Health B: Crit. Rev. 2011, 14:387-412.
42. Metcalfe C.D., Miao X.S., Koenig B.G., Struger J. Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada. Environ. Toxicol. Chem. 2003, 22:2881-2889.
43. Morando M.B., Medeiros L.R., McDonald M.D. Fluoxetine treatment affects nitrogen waste excretion and osmoregulation in a marine teleost fish. Aquat. Toxicol. 2009, 93:253-260.
44. Muneoka K., Shirayama Y., Takigawa M., Shioda S. Brain region-specific effects of short-term treatment with duloxetine, venlafaxine milnacipran and sertraline on monoamine metabolism in rats. Neurochem. Res. 2009, 34:542-555.
45. Painter M.M., Buerkley M.A., Julius M.L., Vajda A.M., Norris D.O., Barber L.B., Furlong E.T., Schultz M.M., Schoenfuss H.L. Antidepressants at environmentally relevant concentrations affect predator avoidance behavior of larval fathead minnows (Pimephales promelas). Environ. Toxicol. Chem. 2009, 28:2677-2684.
46. Perez V., Puiigdemont D., Gilaberte I., Alvarez E., Artigas F. Augmentation of fluoxetine's antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors. J. Clin. Psychopharmacol. 2001, 21:36-45.
47. Perreault H.A.N., Semsar K., Godwin J. Fluoxetine treatment decreases territorial aggression in a coral reef fish. Physiol. Behav. 2003, 79:719-724.
48. Ramirez A.J., Mottaleb M.A., Brooks B.W., Chambliss C.K. Analysis of pharmaceuticals in fish using liquid chromatography-tandem mass spectrometry. Anal. Chem. 2007, 79:3155-3163.
49. Schultz M.M., Furlong E.T., Kolpin D.W., Werner S.L., Schoenfuss H.L., Barber L.B., Blazer V.S., Norris D.O., Vajda A.M. Antidepressant pharmaceuticals in two US effluent-impacted streams: occurrence and fate in water and sediment, and selective uptake in fish neural tissue. Environ. Sci. Technol. 2010, 44:1918-1925.
50. Stanley J.K., Ramirez A.J., Chambliss C.K., Brooks B.W. Enantiospecific sublethal effects of the antidepressant fluoxetine to a model aquatic vertebrate and invertebrate. Chemosphere 2007, 69:9-16.
51. Thomas M., Joshi P.P., Klaper R.D. Gene-class analysis of expression patterns induced by psychoactive pharmaceutical exposure in fathead minnow (Pimephales promelas) indicates induction of neuronal systems. Comp. Biochem. Physiol. C 2011, 155:109-120.
52. Uphouse L., Hensler J.G., Sarkar J., Grossie B. Fluoxetine disrupts food intake and estrous cyclicity in Fischer female rats. Brain Res. 2006, 1072:79-90.
53. Webb S.F. A data based perspective on the environmental risk assessment of human pharmaceuticals II - aquatic risk characterization. Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks 2001, 265. Springer, Berlin/New York. K. Kümmerer (Ed.).
54. Winder V.L., Sapozhnikova Y., Pennington P.L., Wirth E.F. Effects of fluoxetine exposure on serotonin-related activity in the sheepshead minnow (Cyprinodon variegatus) using LC/MS/MS detection and quantitation. Biochem. Physiol. C: Toxicol. Pharmacol. 2009, 149:559-565.